뇌심부 자극 기기 시장 규모, 점유율, 성장 분석, 제품 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Deep Brain Stimulation Devices Market Size, Share, and Growth Analysis, By Product Type (Single-channel DBS Devices, Dual-channel DBS Devices), By Application (Epilepsy, Pain Management), By End User, By Region - Industry Forecast 2025-2032
상품코드:1663028
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
뇌심부 자극(DBS) 기기 세계 시장 규모는 2023년 15억 4,000만 달러로 평가되었습니다. 2024년 16억 8,000만 달러에서 2032년에는 34억 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 9.2%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 뇌심부 자극 기기 시장은 파킨슨병 및 본태성 진전증과 같은 신경질환의 유병률 증가와 효과적인 치료 솔루션에 대한 수요 증가로 인해 견조한 성장세를 보이고 있습니다. 수명이 긴 충전식 장치와 타겟팅 시스템의 개선 등 DBS 기술의 발전으로 시술의 효과와 안전성이 향상되고 있으며, DBS가 신뢰할 수 있는 치료법으로 받아들여지고 환자와 의료진의 인식이 높아진 것도 시장 확대에 크게 기여하고 있습니다. 선진국의 우호적인 상환 정책과 신흥국 시장의 헬스케어 투자 확대는 제조업체의 성장 기회를 더욱 촉진하고 있습니다. 전반적으로, 이러한 요인들이 수렴함에 따라 DBS 장치 시장은 향후 몇 년동안 큰 발전을 이룰 것으로 보입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
뇌심부 자극 기기 시장 규모 : 제품 유형별
시장 개요
싱글 채널 DBS 기기
듀얼 채널 DBS 기기
뇌심부 자극 기기 시장 규모 : 용도별
시장 개요
간질
통증 관리
본태성 진전
강박성 장애(OCD)
파킨슨병
우울증
근육긴장이상
기타
뇌심부 자극 기기 시장 규모 : 최종사용자별
시장 개요
병원
신경과 클리닉
외래수술센터(ASC)
연구센터
기타
뇌심부 자극 기기 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
전년대비 매출 비교(2022-2024년)
주요 기업 개요
Medtronic Plc.(USA)
Abbott Laboratories(USA)
Boston Scientific Corporation(USA)
Aleva Neurotherapeutics S.A.(Switzerland)
Beijing PINS Medical Co., Ltd.(China)
Brainsway Ltd.(USA)
NeuroPace Inc.(USA)
Functional Neuromodulation Ltd.(USA)
NeuroSigma, Inc.(USA)
Beijing Pinchi Medical Equipment Co., Ltd.(China)
SceneRay Corporation Ltd.(China)
Sapiens Steering Brain Stimulation(Netherlands)
Renishaw plc(UK)
Synapse Biomedical Inc.(USA)
Deep Brain Innovations LLC(USA)
Newronika S.p.A.(Italy)
Nexstim Plc(Finland)
Neuronetics, Inc.(USA)
Magstim Company Limited(UK)
Bioinduction Ltd.(UK)
결론과 제안
LSH
영문 목차
영문목차
Global Deep Brain Stimulation Devices Market size was valued at USD 1.54 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).
The global deep brain stimulation (DBS) device market is experiencing robust growth, driven by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor, which has intensified the demand for effective treatment solutions. Advances in DBS technology, including longer-lasting rechargeable devices and improved targeting systems, have enhanced procedural efficacy and safety. Increased acceptance of DBS as a credible treatment, along with heightened awareness among patients and healthcare professionals, contributes significantly to market expansion. Favorable reimbursement policies in developed regions and escalating healthcare investments in emerging markets are further propelling growth opportunities for manufacturers. Overall, the convergence of these factors positions the DBS device market for substantial advancement in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Deep Brain Stimulation Devices Market Segments Analysis
Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Deep Brain Stimulation Devices Market
The Global Deep Brain Stimulation Devices market is primarily driven by innovations in technology that have markedly enhanced patient outcomes and broadened the array of conditions that can be effectively treated. Key advancements include the creation of highly accurate targeting systems and refined stimulation parameters, alongside the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological improvements facilitate personalized treatment regimens, optimize symptom management, and lessen potential side effects, thereby strengthening the overall efficacy and safety of deep brain stimulation therapy. As a result, the market is experiencing robust growth fueled by these transformative developments.
Restraints in the Global Deep Brain Stimulation Devices Market
The global deep brain stimulation devices market faces significant restraints primarily due to the complexity of these devices, which necessitate precise implantation surgeries conducted by highly skilled neurosurgeons. The overall expenses associated with these devices-encompassing the hardware, leads, and programming systems-can be quite high. Furthermore, the costs associated with the surgical procedure increase as they require specialized equipment, operating room facilities, and extensive post-operative care. This high financial burden presents a barrier to affordability and accessibility, particularly in regions where healthcare resources are scarce or insurance coverage is insufficient, limiting the market's potential growth.
Market Trends of the Global Deep Brain Stimulation Devices Market
The Global Deep Brain Stimulation (DBS) Devices market is witnessing significant growth, largely fueled by the rising prevalence of neurological disorders, particularly among the aging population. Conditions such as Parkinson's disease, essential tremor, and dystonia are becoming increasingly common due to factors like chronic disease proliferation and exposure to environmental toxins. As awareness about DBS as a highly effective treatment option spreads, there is a marked increase in demand for these devices. This trend underscores a shifting focus towards innovative surgical interventions in neurology, positioning the DBS market for robust expansion in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2025-2032)
Market Overview
Single-channel DBS Devices
Dual-channel DBS Devices
Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2025-2032)
Market Overview
Epilepsy
Pain Management
Essential Tremor
Obsessive Compulsive Disorder (OCD)
Parkinson's Disease
Depression
Dystonia
Others
Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
Others
Global Deep Brain Stimulation Devices Market Size & CAGR (2025-2032)
North America (Product Type, Application, End User)
US
Canada
Europe (Product Type, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Medtronic Plc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Abbott Laboratories (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boston Scientific Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Aleva Neurotherapeutics S.A. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Beijing PINS Medical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Brainsway Ltd. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
NeuroPace Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Functional Neuromodulation Ltd. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
NeuroSigma, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Beijing Pinchi Medical Equipment Co., Ltd. (China)